[Treatment of Heavily Calcified Coronary Lesions]

Alexandru Patrascu1, Maciej Cieslik1, Christian Templin1

  • 1Klinik für Kardiologie, Universitätsspital Zürich.

Insights

Coronary heart disease (CHD) is a leading cause of death, often involving calcified coronary lesions that complicate percutaneous coronary intervention (PCI). This work reviews current therapeutic approaches for PCI in these challenging calcified vessels.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Vascular Medicine

Background:

  • Coronary heart disease (CHD) is a primary cause of adult mortality in industrialized nations.
  • Stenosis in epicardial coronary arteries leads to reduced blood supply, causing symptoms like chest pain and potentially myocardial infarction, heart failure, or arrhythmia.
  • Despite advancements in percutaneous coronary intervention (PCI) and stenting, heavily calcified coronary lesions present significant challenges, hindering stent implantation and increasing complication risks.

Purpose of the Study:

  • To review current therapeutic strategies for performing percutaneous coronary intervention (PCI) in patients with heavily calcified coronary lesions.
  • To highlight the challenges posed by calcified coronary stenoses in interventional cardiology practice.
  • To discuss the limitations in preventing coronary artery calcification.

Main Methods:

  • Literature review of therapeutic approaches for PCI in calcified coronary vessels.
  • Analysis of challenges and complications associated with treating calcified coronary lesions.
  • Discussion of current interventional cardiology techniques.

Main Results:

  • Heavily calcified coronary lesions are a significant barrier to successful stent implantation and expansion during PCI.
  • These lesions are associated with a higher incidence of procedural complications.
  • Currently, no established methods exist to prevent the progression of coronary artery calcification.

Conclusions:

  • Percutaneous coronary intervention (PCI) in heavily calcified coronary lesions remains a complex challenge in interventional cardiology.
  • While preventive strategies for coronary calcification are lacking, various therapeutic approaches facilitate PCI in these vessels.
  • Further research and technological advancements are needed to improve outcomes for patients with calcified coronary artery disease.

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
124
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
113
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
113
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
219
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
123
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
95